UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000024255 |
|---|---|
| Receipt number | R000027802 |
| Scientific Title | Vascular regeneration therapy using autologous peripheral blood mononuclear cells for refractory skin ulcer associated with connective tissue diseases and vasculitis |
| Date of disclosure of the study information | 2016/11/23 |
| Last modified on | 2022/10/06 17:27:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/10/02 13:46:21 | ||
| 2 | Update | 2017/03/12 14:33:33 | Date of protocol fixation Anticipated trial start date |
|
| 3 | Update | 2017/08/15 16:03:19 | Condition Condition Classification by specialty Narrative objectives1 Narrative objectives1 Basic objectives2 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2017/08/15 16:09:01 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2017/08/15 16:23:24 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
| 6 | Update | 2017/08/28 10:51:22 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 7 | Update | 2017/09/09 05:05:06 | Public title Public title Acronym Acronym |
|
| 8 | Update | 2017/09/09 05:20:12 | Condition Condition Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
| 9 | Update | 2017/09/09 05:23:59 | Key exclusion criteria Key exclusion criteria |
|
| 10 | Update | 2018/03/09 08:49:11 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 11 | Update | 2018/03/09 08:51:39 | UMIN ID1 |
|
| 12 | Update | 2020/10/05 14:18:34 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Institute Organization Organization Organization Address Address Tel |
|
| 13 | Update | 2021/04/16 18:34:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator |
|
| 14 | Update | 2021/04/16 18:40:37 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 15 | Update | 2021/04/16 18:42:40 | Date of IRB |
|
| 16 | Update | 2022/10/06 17:27:40 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
